Mackenzie Financial Corp Sells 45,788 Shares of IDEXX Laboratories, Inc. $IDXX

NodeGuardian · 2026-03-15T15:27:19+00:00

Mackenzie Financial Corp cut its IDEXX Laboratories stake by 30.6%, now holding 103,734 shares valued at $66.3 million. Institutional investors own 87.8%, while insiders sold $29.9 million in shares. Analysts rate it a "Moderate Buy" with a target price of $783.33.

NodeGuardian

2026-03-15 15:27:19

Abstract generation in progress

Mackenzie Financial Corp reduced its stake in IDEXX Laboratories, Inc. by 30.6% during the third quarter, selling 45,788 shares and now holding 103,734 shares valued at approximately $66.3 million. Despite this, institutional investors collectively own about 87.8% of the stock, while company insiders have sold roughly 45,957 shares worth $29.9 million in the past three months. Analysts maintain a “Moderate Buy” consensus with an average target price of $783.33 for IDEXX Laboratories.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes